Researcher biography

Researcher Biography

Dr Snehlata Kumari completed her PhD in the University Clinic at the Department of Dermatology in Cologne, Germany on understanding the role of NF-kB signaling in regulating skin inflammation. During her PhD, she received intensive training in skin immunity and moved to the Institute for Genetics at the University of Cologne in Germany to do postdoctoral work. Dr Kumari made fundamental discoveries in identifying essential roles of NF-kB signaling, cytokine signaling, and apoptosis and necroptosis signaling pathways in regulating skin homeostasis and inflammation. These findings advanced the knowledge of skin immunity, and opened up new avenues for novel potential targets in skin inflammation. At the forefront of skin immunity research, these findings were published in leading journals such as Nature and Immunity.

Dr Kumari's contributions received recognition from the national and international scientific communities including the German National Academy of Sciences- Leopoldina, International Investigative Dermatology and European Society for Dermatological Research. She was awarded a career development grant on melanoma research from the German Research Foundation-SFB 829.

Dr Kumari is Research Leader at The University of Queensland Diamantina Institute. Her laboratory currently focuses on identifying and understanding immuno-modulatory mechanisms controlling inflammatory skin diseases and skin cancer.

Overall aims and research focus

The aim of the Kumari Group is to identify immuno-modulatory signals and understand cellular and molecular mechanisms controlling inflammatory diseases like psoriasis, and skin cancer. Using multi-dimensional and cutting-edge methodologies in Immunology, Biochemistry, Cell- and Molecular Biology, and in vivo, in vitro and 3D culture systems, we aim to achieve the overarching goal of bringing fundamental scientific discoveries in skin immunity at the forefront to develop better therapeutic strategies.

Our research focuses on

  • Identifying new immune regulatory mechanisms and signals involved in skin inflammation.
  • Elucidating cellular and molecular signaling mechanisms regulating skin immune homeostasis.
  • Investigating tumor-intrinsic mechanisms and innate immunity to develop novel therapeutics and immunotherapy for skin cancer (melanoma and non-melanoma).